---

The efficacy of nasolabial flap as a reconstruction modality in the surgical management of oral submucous fibrosis

---

Original Article

Author Details : Mugdha Milind Parkhi*, K.C. Gupta, Ashish Fanan

Volume : 8, Issue : 3, Year : 2022

Article Page : 92-97

https://doi.org/10.18231/j.ijashnb.2022.022

Suggest article by email

Get Permission

---

Abstract

The purpose of this study was to clinically assess the efficacy of nasolabial flap for reconstruction of oral cavity defects post fibrotomy in oral submucous fibrosis (OSMF) patients. The study was implemented on ten patients with OSMF with mouth openings of less than 10 mm interincisal distance. The extent of mouth opening (inter incisal distance) along with the viability and vascularity of the flap was evaluated clinically over a period 6 months. In our study, complications like flap necrosis, flap loss, infection and obstructive sialadenitis were not observed. However, intra-oral hair growth was seen in our 7 patients, extra-oral scar at the donor site was seen in all our patients and salivary fistula formation was reported in 1 of the patient which underwent fistula repair later. Mean mouth opening of 37 mm was achieved at 6 months post-operatively, with a mean increase of 31.5 mm. No relapse was encountered, even at last follow-up. On the basis of the results, we conclude that the inferiorly based nasolabial flap is an efficacious, viable and a reliable option for reconstruction of oral cavity defects in OSMF.

Keywords: Nasolabial flap, Oral submucous fibrosis, Reconstruction

How to cite : Parkhi M M, Gupta K, Fanan A, The efficacy of nasolabial flap as a reconstruction modality in the surgical management of oral submucous fibrosis. IP Indian J Anat Surg Head Neck Brain 2022;8(3):92-97

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.